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Alterations in genes involved in the repair of DNA
mutations (mut genes) result in an increased mutation fre-
quency and better adaptability of the bacterium to stressful
conditions. W-Beijing genotype strains displayed unique
missense alterations in three putative mut genes, including
two of the mutT type (Rv3908 and mutT2) and ogt. These
polymorphisms were found to be characteristic and unique
to W-Beijing phylogenetic lineage. Analysis of the mut
genes in 55 representative W-Beijing isolates suggests a
sequential acquisition of the mutations, elucidating a plau-
sible pathway of the molecular evolution of this clonal fam-
ily. The acquisition of mut genes may explain in part the
ability of the isolates of W-Beijing type to rapidly adapt to
their environment.
T
uberculosis (TB) and AIDS cause more deaths in
adults worldwide than any other infectious disease.
Globally, the number of TB cases is growing at a rate of
2% per year. Resistance, especially multidrug-resistance
(MDR), is an increasing problem (1) and a growing hazard
to human health. Many outbreaks of MDR-TB, defined as
resistance to at least rifampicin and isoniazid, have been
reported, with poor response to therapy and very high dis-
ease and death rates. Some TB outbreaks have involved
patients with HIV co-infection (2,3). Although in several
instances, MDR outbreaks associated with a particular
genotype, such as the W strain, have been identified (4,5),
drug-susceptible variants of the W strain account for most
of this group of isolates characterized to date. 
In 1995, the largest proportion of the Mycobacterium
tuberculosis strains from Beijing, China, shared a high
degree of similarity in IS6110 restriction fragment length
polymorphism (RFLP) patterns and identical spoligo pat-
terns (6). Subsequent molecular analyses have indicated
that the W and Beijing isolates constitute a single group of
strains designated as the W-Beijing genotype (Figure 1).
The global distribution and success of M. tuberculosis iso-
lates of the W-Beijing genotype have led to the hypothesis
that these strains may have selective advantages over other
M. tuberculosis strains. In addition to the W-MDR strain
identified in New York City, and areas in Cuba, Estonia,
Vietnam, and Russia, the W-Beijing genotype has been
significantly associated with drug resistance (7 and unpub.
data). Several studies have suggested that the W-Beijing
genotype strains are disseminating throughout the world
(7). In Vietnam, the proportion of W-Beijing strains was
71% in patients <25 years of age and 41% for those >25
years of age (8). Furthermore, W-Beijing strains have been
implicated in several TB epidemics globally, including
ones in New York, Texas, California, South Carolina, and
New Jersey in the United States (9) and South Africa,
Russia, and Spain (10). Arecent study showed that 82% of
MDR strains isolated in a prison in Azerbaijan, Eastern
Europe, are of the W-Beijing genotype (11). 
Ongoing research is focused on identifying the factors
responsible for the worldwide spread of the W-Beijing
strains and their ability to adapt and enhance their patho-
genicity or virulence. Identifying a possible mechanism for
increased adaptation of these bacteria to the human
immunologic host defense system or human interventions
such as anti-TB treatment is of the utmost importance.
Such mechanisms may indicate how the bacterium adapts
to the host, a prerequisite for an enhanced accumulation of
genomic mutations associated with resistance. In M. tuber-
culosis, resistance to antibiotics occurs because of genom-
ic mutations in certain genes, such as the katG gene for iso-
niazid (INH) resistance and the rpoB gene for rifampicin
resistance (12). In contrast to several other pathogens with
MDR phenotypes, plasmid or transposon-mediated mech-
anisms of resistance have not been reported in M. tubercu-
losis (13–15). Since resistance to bacteriostatic in M.
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Recent studies provided evidence for a role of mutator
phenotypes in the emergence of MDR clinical
Pseudomonas isolates (16). Such phenotypes not only
enable the bacteria to acquire resistance to antibiotics more
easily but also facilitate their adaptation to a new niche.
Bacteria can escape immune surveillance by modulating
bacterial resistance to host defense mechanisms (16–18).
This finding prompted us to investigate whether a similar
situation exists in M. tuberculosis. We have undertaken a
comprehensive comparative sequence analysis of selected
target genes to evaluate and study the presence of muta-
tions in putative genes expected to play a role in the muta-
tion frequency in such strains. 
Mutated phenotypes commonly result from defects in
DNA repair (19). An in silico analysis suggested that most
mismatch repair systems (e.g., mutS, mutL, or mutH) were
missing in the M. tuberculosis genome (20). However, the
frequency of spontaneous mutations in M. tuberculosis (in
vitro cultures) is similar to that found in other bacteria-car-
rying mismatch repair systems (21), which suggests that
other DNA repair mechanisms must be present.
Hypothetical open reading frames (ORF), similar to genes
known to be responsible for the avoidance or repair of
DNA lesions resulting from the alkylation or oxidation of
nucleotides, are present in the genome of M. tuberculosis.
We searched for variations in these genes in 139 clinical
isolates to detect possible mutations that could allow an
enhanced adaptability to the host and increased resistance
to anti-TB drugs.
Methods
We searched for mut genes variation in 139 M. tubercu-
losis complex strains originating from 35 different coun-
tries. Ninety-four of these strains were selected because
they were representative strains characterized with 13 dif-
ferent genetic markers in previous studies (6,22). 
This set comprised 125 M. tuberculosis strains, 1 M.
africanum, 8 M. bovis, 3 M. bovis BCG, and 2 M. microti.
Fifty-five strains had a W-Beijing genotype; 12 had an
MDR phenotype. Strains representing different branches
of the W-Beijing genotype were studied. Eight MDR M.
tuberculosis strains with a genotype other than Beijing
were included. Five M. tuberculosis strains of the W-
Beijing genotype and three strains of unrelated genotype
were obtained from the national program for surveillance
of MDR tuberculosis in Spain. Four M. tuberculosis W-
Beijing genotype strains isolated in the Netherlands and
one from Vietnam were included because they showed
spoligo patterns with fewer than nine spacers. Five other
W-Beijing genotype strains showed hybridization to an
additional spacer, as demonstrated by using the extended
set of spacers, two of which lacked hybridization to spac-
er 37. Strain W4 is part of a drug-susceptible outbreak in
New Jersey (4); W147 is a drug-resistant isolate widely
spread in Russia (23). Eleven strains were representative
of ancestral W-Beijing strains, which diverged early in the
evolution of the W-Beijing phylogenetic lineage. Finally,
29 strains of another frequently observed genotype, the
Haarlem genotype (6), were investigated. 
The collection consisted of 55 W-Beijing genotype iso-
lates, 29 Haarlem genotype isolates, 8 strains of the
African genotype, 1 M. bovis strain, and 46 representatives
of other genotypes. Principal genetic grouping (PGG),
according to the polymorphism in katG  and  gyrA, was
known (24) for most of the isolates in this study. Seventy-
four strains belong to PGG 1, 54 to PGG 2, and 3 to PGG
3. All isolates were subjected to at least IS6110 RFLP typ-
ing and spoligotyping (6). Drug susceptibility was deter-
mined for 41 of 139 strains (Table 1 and 2). Several puta-
tive  mut  genes were annotated as such in the released
genome sequence of M. tuberculosis (25). In addition,
using the BLAST program (26), we identified Rv3908 as
an ORF carrying a mutT domain (27) and have since
named it mutT4.
Primers were designed to amplify putative mut genes:
mutY (5'-CCGGCGACGAATCGCTCGTT-3', 5'-
AGCTGGGACAGTCGTCGCGG-3'),  mutM (5'-CTG-
GTTCGATGGTGATGACC-5', 5'-GTGCGCTCGACC-
CACAG-3'), mutT2 (5'-TCCGGATGATGATTTACCTCC-
3', 5'-TCCGCCGGGTCGGGGAC-3'), mutT1 (5'-ATCG-
TCGGCGTGCCGTG-3', 5'-GTCAGCGTCCTGCCCGG-
3'),  mutT4 (5'-TCGAAGGTGGGCAA- ATCGTG-3' 5'-
TGGGGTTCGCTGGAAGTGG–3'),  ogt (5'-CAGCGC-
TCGCTGGCGCC-3', 5'-GACTCAG CCGCTCGCGA-3'),
and  mut T3 (5'-GTCACGTCTGTTAGGACCTC-3', 5'-
CGCGCAACGGCTGCCGG-3'). Similar primers were
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Figure 1. Characteristic patterns
of  Mycobacterium tuberculosis
Beijing genotype strains. RFLP,
restriction fragment length poly-
morphism.designed to amplify the rpoB gene (5'-TACGGTCGGC-
GAGCTGATCC-3', 5'- TACGG- CGTTTCGATGAACC-
3').
DNA sequencing was performed directly on the ampli-
fied fragments by using the dideoxy chain-termination
method with the Big Dye Terminator Cycle sequencing Kit
(Perkin Elmer Applied Biosystems, Courtaboeuf, France)
on a GeneAmp polymerase chain reaction (PCR) system
9600 (Perkin Elmer) and run on a DNA analysis system
model 373 or 3100 (Applied Biosystems). Sequences of
mutY, mutT2, mutT4, rpoB, mutT1, mutT3, and ogt of the
M. tuberculosis strains H37Rv, CDC1551, and MT210
were obtained from published sequences or at the TIGR
Web site (available from: URL: http://www.tigr.org/).
Results
We searched for allele variation in putative genes cod-
ing for DNA repair enzymes: mutT (which hydrolyzes 8-
oxo-deoxyguanosine triphosphate) (28), ogt  (which
removes methyl groups from O6-methylguanine in DNA)
(29), mutM  (formamidopyrimidine-DNA glycosylate)
(30), and mutY (specific adenine glycosylate) (31) in 12
MDR M. tuberculosis strains. Subsequently, we genotyped
for the observed single nucleotide polymorphism (SNP)
variation in 124 strains, members of the M. tuberculosis
complex, and in the three published sequences of M. tuber-
culosis strains. In total, the sampling comprises 55 W-
Beijing genotype M. tuberculosis strains, including 11
ancestral W-Beijing isolates (unpub. data ), 84 M. tubercu-
losis strains of other genotypes, and 1 M. bovis strain.
Several putative mut genes were annotated as such in
the released genome sequence of M. tuberculosis. A
BLAST search using the E. coli mutT sequences as tem-
plate identified, in addition to mutT1, mutT2, mutT3, the
hypothetical ORF Rv3908, which we have designated as
mutT4. The best matches with E. coli mutT gene were
observed for mutT2 and mutT4. Figure 2 depicts sequence
alignment of the conserved region of the different genes of
the M. tuberculosis genome showing similarity with mutT
of E. coli. The search for sequences similar to ogt, mutM,
and mutY identified a single ORF in each case. Primers
were designed for PCR amplification of all the genes men-
tioned above.
We first determined the sequences of the different
genes mentioned above in 12 MDR M. tuberculosis strains
(ZA20, ZA65, ZA67, ZA68, ZA69, ZA11, ZA16, ZA12,
ZA13, ZAA14, ZA17, and ZA19), including 5 W-Beijing
strains (ZA20, ZA65, ZA67, ZA78, and ZA69). For the
mutY,  mutM,  mutT1, and mutT3 putative genes, PCR
amplification was obtained in all strains tested, but
sequence analysis did not indicate any nucleotide changes
at these loci except for the same silent SNP in mutT3 in
strains with a Haarlem genotype. We confirmed these find-
ings by sequencing mutT1, mutT3, mutM, and mutY in a
collection of 26 MDR strains from North Africa. No vari-
ation was observed in mutT1 or mutM. Only one strain had
a major variation in mutY. All Haarlem strains carried one
characteristic silent mutation in mutT3 and one character-
istic mutation in ogt (Ser 15 replaced by Thr). These defin-
ing SNPs were also observed for all Haarlem strains of this
study. No other variations were observed in mutT1, mutT3,
mutM, or mutY. However, comparative sequence analysis
of H37Rv, CDC1551, and the five MDR–W-Beijing iso-
lates indicated polymorphisms in mutT2, mutT4, and ogt.
These mutations in mutT4, mutT2, and ogt were also found
in the W-Beijing strain 210 (TIGR) but not in MDR strains
other than those belonging to the W-Beijing genotype. We
therefore decided to extend this investigation and look for
mutations in these three genes in a collection of M. tuber-
culosis complex isolates, including well-defined branches
of the W-Beijing phylogenetic lineage (Table 1 and 2).
In 43 of 55 strains with a W-Beijing genotype, either
susceptible to bacteriostat or MDR, we found a mutation in
mutT4. Codon 48 (CGG) of the annotated ORF had been
changed to GGG, resulting in the amino acid substitution
of Arg by Gly (Table 1 and 2). All 11 W-Beijing isolates
known to be closely related to the ancestral W-Beijing
strain (AM, HI, N16, DU2, DV, LB2, KY, IK, 122(C11),
113, and 107(LB)) were found to have the wild-type geno-
type as all other 84 isolates with a genotype other than W-
Beijing. 
Thirty-nine of 43 W-Beijing strains with the mutation
in mutT4 carried an additional mutation in mutT2 and in
ogt. The mutT2 mutation constitutes a change in codon 58
(GGA to CGA), resulting in an amino acid substitution of
Gly by Arg. The active site of the E. coli MutT enzyme
comprises amino acids 53, 56, 57, and 98. Therefore, a
mutation Gly to Arg at position 58 may have a important
effect on enzyme activity and lead to a mutator phenotype.
All 39 W-Beijing isolates carrying the mutT2 polymor-
phism at codon 58 also displayed a concurrent silent muta-
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Figure 2. MutT proteins’ sequences alignment. Mycobacterium
tuberculosis Rv2985(MutT1), Rv1160(MutT2), Rv0413(MutT3),
and Rv3908(MutT4) were selected from the M. tuberculosis
genome because of their annotation or after a BLAST analysis.
These sequences were compared to Escherichia coli mutT by
using alignments available from: URL: http://www.biochem.uthsc-
sa.edu/~barnes/mutt.html. The detected region of similarity is
shown here. # absolutely conserved residues; * residues that are
strongly conserved and that define the mutT or nudix motif.tion in codon 12 (Gly GGG to GGA Gly) of the ogt gene.
Of four possible codons encoding for glycine, GGG and
GGA had the lowest relative synonymous codon usage
(RSCU) in genes with high expression levels (0.20 and
0.17, respectively, compared to 1.32 and 2.31 for GGU and
GGC). For genes with low expression levels, the RSCU
values are 0.92, 0.37, 0.65, and 2.06 for GGG, GGA, GGU,
and GGC, respectively (32). 
The five W-Beijing isolates with a mutation in mutT4
and a wild-type mutT2 gene did not contain the ogt silent
mutation on codon 12 either. Instead, they all shared a din-
ucleotide substitution in codon 37 (ACC to CTC) of ogt,
resulting in amino acid substitution of Arg to Leu. These
five W-Beijing isolates of 43 with the mutT4 mutations,
without the mutT2 (codon 58) or the ogt (codon 12) muta-
tions, differed molecularly from all other W-Beijing iso-
lates in their spoligotype pattern and accompanying dele-
tion flanking the DR locus. Four of five were isolated from
Dutch patients in the Netherlands; the fifth originated from
a patient in Vietnam. The Vietnamese isolate (no. 94)
shared >95% IS6110 pattern similarity with the Dutch iso-
late 115 when standard RFLP analysis was used. Overall,
the five isolates were closely related to each other accord-
ing to IS6110 profiling (>90% similarity). Spacer 37 in the
DR locus of Dutch isolates 114 and 139 was absent, while
sample 115 was missing spacers 37 and 38, and 111 had a
deletion of spacers 38 and 39 but not spacer 37, suggesting
that these isolates may belong to a different sublineage. A
tentative phylogeny of the W-Beijing strains analyzed in
this study is proposed in Figure 3. Seven of nine MDR W-
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Table 1. Characteristics of Mycobacterium tuberculosis complex strains originating from 35 different countries  
Strains  Genotype 
No. 
isolates 
Country of 
isolation  Group  mutT2  mutT4  ogt 
ZA20/65  W-Beijing  2  Spain  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
ZA67-69  W-Beijing  3  Spain  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
ZA11/16  Haarlem  2  Spain  2  wt  wt  Thr ACC 15 Ser AGC 
ZA12-14/17  other  4  Spain  nd  wt  wt  wt 
ZA19  M. bovis  1  Spain    wt  wt  wt 
ZA15  other  1  Spain  nd  wt  wt  wt 
ZA60-62  W-Beijing  3  Spain  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
CDC1551    1  USA  2  wt  wt  wt 
H37Rv    1  USA  3  wt  wt  wt 
MT210  W-Beijing  1  USA  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
20  W-Beijing  1  Mongolia  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
30  W-Beijing  1  South Africa  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
34  W-Beijing  1  Malaysia  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
43  W-Beijing  1  China  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
44  W-Beijing  1  Thailand  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
45  W-Beijing  1  Malaysia  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
91/102-6  W-Beijing  6  Vietnam  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
110/116/119/12
4-5/140-2 
W-Beijing  8  the Netherlands  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
133  W-Beijing  1  South Africa  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
W4/10/126/129  W-Beijing  4  USA  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
W99  W-Beijing  1  Singapore  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
W147  W-Beijing  1  Russia  1  Gly GGA 58 CGA Arg  Arg CGG 48 GGG Gly  Gly GGG 12 Gly GGA 
94  W-Beijing  1  Vietnam  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
111  W-Beijing  1  South Korea  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
115  W-Beijing  1  the Netherlands  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
5107(HG1)  W-Beijing  1  USA  1  wt  Arg CGG 48 GGG Gly  Arg CGC 37 Leu CTC 
114, 139  W-Beijing  1  the Netherlands  1  wt  Arg CGG 48 GGG Gly  wt 
166(HD6)  W-Beijing  1  USA  1  wt  Arg CGG 48 GGG Gly  wt 
165(001)  W-Beijing  1  USA  1  wt  wt  Arg CGC 37 Leu CTC 
107(LB)  W-Beijing  1  USA  1  wt  wt  wt 
113  W-Beijing  1  the Netherlands  1  wt  wt  wt 
122(CI1)  W-Beijing  1  USA  1  wt  wt  wt 
IK/KY/LB2/DV
/DU2/HI 
W-Beijing  6  Russia  1  wt  wt  wt 
N16  W-Beijing  1  USA  1  wt  wt  wt 
AM  W-Beijing  1  USA  1  wt  wt  wt 
awt, wild-type alleles (identical to H37Rv strain); nd, not determined Beijing strains carried missense mutations in two muT
genes (mutT2 and mutT4), and two had a missense muta-
tion in both mutT4 and ogt (Table 1 and 2). 
No mutations in mutT4 or in mutT2 were observed in
any of the 84 M. tuberculosis complex strains, including
19 strains of PGG1, 54 strains of PGG2, and 2 strains of
PGG3; the strains originated from 29 countries and were a
genotype other than W-Beijing. A Thr15Ser mutation was
observed in 24 of 29 strains of the Harlem family. No other
change was observed in ogt.
Resistance to rifampicin in MDR strains was correlated
with mutations in the rpoB gene. The three tested MDR W-
Beijing strains isolated in Spain, with the mutations at the
mutT2 and mutT4 loci, harbored a different mutation in the
rpoB gene. These strains were isolated from patients who
had emigrated from Eastern Europe to Spain (ZA67,
842 Emerging Infectious Diseases • Vol. 9, No. 7, July 2003
RESEARCH
Table 2. Characteristics of Mycobacterium tuberculosis complex strains originating from 35 different countries 
Strains  Genotype  No. isolates  Country of isolation  Group  mutT2  mut T4  ogt 
AU  Haarlem  1  USA  2  wt  wt  Thr ACC 15 Ser AGC 
3,5,22,32,39,48,50
,52-3,55 
Haarlem  10  Argentina  2  wt  wt  Thr ACC 15 Ser AGC 
8  Haarlem  1  Vietnam  2  wt  wt  Thr ACC 15 Ser AGC 
13/28  Haarlem  2  Sri Lanka  2  wt  wt  Thr ACC 15 Ser AGC 
51  Haarlem  1  the Netherlands  2  wt  wt  Thr ACC 15 Ser AGC 
57/59  Haarlem  2  Czech republic  2  wt  wt  wt 
84  Haarlem  1  Czech Republic  2  wt  wt  Thr ACC 15 Ser AGC 
86/143/145  Haarlem  3  Bolivia  2  wt  wt  Thr ACC 15 Ser AGC 
87  Haarlem  1  USA  2  wt  wt  Thr ACC 15 Ser AGC 
99  Haarlem  1  Italy  2  wt  wt  Thr ACC 15 Ser AGC 
123  Haarlem  1  Czech Republic  2  wt  wt  Thr ACC 15 Ser AGC 
144/146-7  Haarlem  3  Bolivia  2  wt  wt  wt 
Apr-35  Africa  2  Rwanda  2  wt  wt  wt 
37  Africa  1  Uganda  2  wt  wt  wt 
40/120  Africa  2  Burundi  2  wt  wt  wt 
72  Africa  1  Central African Republic  2  wt  wt  wt 
97  Africa  1  Uganda  2  wt  wt  wt 
121  Africa  1  Central African Republic  2  wt  wt  wt 
2  BCG  1  the Netherlands  1  wt  wt  wt 
6/47/73/130  M. bovis  4  the Netherlands  1  wt  wt  wt 
12  Other  1  Tunisia  3  wt  wt  wt 
15/31  Other  2  Iran  2  wt  wt  wt 
16  Other  1  Canada  2  wt  wt  wt 
17  Other  1  Greenland  2  wt  wt  wt 
18  Other  1  USA  2  wt  wt  wt 
19/36/74  Other  2  India  1  wt  wt  wt 
25/62  M. microti  2  UK  1  wt  wt  wt 
26  Other  1  Zimbabwe  2  wt  wt  wt 
27  Other  1  Ethiopia  2  wt  wt  wt 
38/42  Other  2  Tahiti  2  wt  wt  wt 
41/46  Other  2  Chile  2  wt  wt  wt 
49  Other  1  Tanzania  1  wt  wt  wt 
56  Other  1  Curacao  2  wt  wt  wt 
64  Other  1  Honduras  2  wt  wt  wt 
65/112  Other  2  the Netherlands  1  wt  wt  wt 
71  BCG  1  Japan  1  wt  wt  wt 
76/101/126  M. bovis  3  Argentina  1  wt  wt  wt 
83  BCG  1  Russia  1  wt  wt  wt 
89/95  Other  2  Spain  2  wt  wt  wt 
96  Other  1  the Netherlands  3  wt  wt  wt 
98  Other  1  Ecuador  2  wt  wt  wt 
100  M. africanum  1  the Netherlands  1  wt  wt  wt 
108  Other  1  China  2  wt  wt  wt 
118  Other  1  Honduras  2  wt  wt  wt 
and, not determined; wt, wild-type alleles (identical to H37Rv strain). ZA68, and ZA69). Analysis of the IS6110 RFLP of the
respective isolates showed a difference of a single band.
These findings suggest that the three strains may be relat-
ed. The acquisition of the three different mutations in the
rpoB gene leading to rifampicin resistance must have
occurred after the acquisition of mutations in the putative
nucleotide repair enzyme genes mutT4 and mutT2.
Discussion
Our results show that M. tuberculosis strains of the W-
Beijing genotype acquired missense mutations in DNA
repair genes. These M. tuberculosis W-Beijing genotype
strains are genetically highly conserved and widespread.
DNA repair genes have been previously shown to be asso-
ciated with mutator phenotypes in other microorganisms.
The success of this group of strains may result in part from
mutations in DNA repair enzymes, which might provided
a true selective advantage for these bacteria to adapt and
persist, including through the acquisition of resistance to
anti-TB drugs. Mutations in the DNA repair genes might
be the evolutionary answer of the TB bacillus to increase
adaptation to hosts. This adaptation will lead to increasing
trends in the TB epidemic in the coming decades. The
World Health Organization considers MDR and resistance
as a problem of local rather than of global importance (1).
If the relative contribution of W-Beijing genotype strains
to the current worldwide TB epidemic is increasing as sug-
gested (7), this approach should be revised. In areas with
an increasing problem with MDR-TB, such as Estonia and
Russia, W-Beijing genotype strains are predominantly
associated with MDR cases (33). In Germany, the relative
proportion of W-Beijing strains among isolates from resist-
ant cases has increased from 12% in 1995 to 35% in 2000
(unpub. data). The latter observation may indicate an
increasing influence of W-Beijing strains on the worldwide
TB epidemic.
We identify polymorphisms in M. tuberculosis in genes
that might result in a mutator phenotype and therefore a
plausibly better adaptation of the bacilli to a hostile envi-
ronment (34). Forty-three of 55 W-Beijing isolates ana-
lyzed were found to have a unique mutation on the ORF
Rv3908. This ORF contains a MutT domain and is denot-
ed here as mutT4. Thirty-nine of 43 W-Beijing strains car-
ried an additional and identical mutation in a second puta-
tive gene of the mutT family, mutT2, and an identical silent
mutation in ogt. 
The W-Beijing phylogenetic lineage probably acquired
the mutation on codon 48 of the mutT4 only once and
before other mutations associated with the mutator genes
we describe. This mutation clearly distinguishes ancestral
W-Beijing isolates from contemporary W-Beijing strains.
The 11 W-Beijing isolates that did not have the character-
istic mutT4 mutation on codon 48, consist of a collection
of isolates known to be ancestral within this phylogenetic
lineage, as determined by various other molecular tech-
niques (unpub. data). 
Nine of W-Beijing strains with the wild-type mutT2
gene had a characteristic mutation on codon 37 of the ogt
gene, which suggests that these isolates constitute a branch
of the W-Beijing family that diverged after the acquisition
of the mutT4 mutation but before the development of the
nucleotide substitution on mutT2. One strain carries the
mutation 37 in ogt but no mutation in mutT4, a reversion
that might have occurred after a transient mutator pheno-
type.
A mutation in mutT2 was always associated with a
mutation in muT4. A first mutation may have occurred in
mutT4 and thereafter a second mutation either in mutT2 or
ogt was acquired. As observed for other bacterial popula-
tions, mutator phenotypes may be transient in many cases
to limit deleterious effects (35). Identifying these muta-
tions may aid in the identification of mut  genes in M.
tuberculosis. These mutations associated with mutator
genes provide a reliable tool for the identification of W-
Beijing isolates and thus a useful marker for strains
endowed with capacity to yield epidemics. The biologic
consequences of these mutations and function of these
DNA repair genes are currently been investigated in the
laboratory.
Nine MDR strains with a W-Beijing genotype were
among strains carrying two missense mutations in putative
mutator genes. Phylogenetically unrelated M. tuberculosis
MDR isolates had no mutations within the DNA repair
genes investigated in this study. Our data support the idea
that M. tuberculosis strains of the W-Beijing genotype may
have adapted to hostile environments, including exposure
to anti-TB drugs, because of a succession of alterations of
DNA repair enzymes. Other genes involved in other DNA
repair mechanisms or in the fidelity of DNA replication
may also be involved and remain to be investigated.
The acquisition of mutator alleles was described as an
adaptive response of bacteria to a succession of different
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Figure 3. Schematic representation of a plausible pathway to
explain the accumulation of mutations in mut genes.environments (18,35,36). After infecting a host, M. tuber-
culosis has to adapt to different environments such as alve-
olar macrophages and dendritic cells and subsequently to
granuloma containing inactivated macrophages or to acti-
vated macrophages after induction of the acquired immune
responses. In addition, the bacilli have to adapt to the
caseous media with low oxygen concentration in the cen-
ter of tubercles and to different types of tissues during dis-
semination of the disease. Such variable growth conditions
might select for mutations in M. tuberculosis strains, as
described in other bacterial populations exposed to differ-
ent environmental challenges. Mutations and selection
might occur with an increased frequency caused by the
toxic radicals produced in phagocytic cells. 
However, a mutator phenotype is often transient.
Otherwise a continual accumulation of mutations would
lead to deleterious effects and loss of fitness. No difference
in the frequency of spontaneous mutations, resulting in a
rifampin resistance phenotype, was observed for W-
Beijing strains (37). We suggest that a transient mutator
phenotype allowed a better adaptation of W-Beijing
strains. Subsequent compensatory mutations occurred to
reverse the mutator phenotype. An alternative hypothesis
would be the existence of a higher mutation rate in specif-
ic conditions (i.e., in mutagenic radicals inside phago-
cytes). The accumulation of mutations leading to antibiot-
ic resistance in W-Beijing strains may be a consequence of
the appearance of strains with a better adaptation to the
hosts. MDR strains would be easily selected when patients
with strains that have adapted better received inadequate
anti-TB regimens.
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